CNTN5

Chr 11

contactin 5

Also known as: HNB-2s, NB-2

The protein encoded by this gene is a member of the immunoglobulin superfamily, and contactin family, which mediate cell surface interactions during nervous system development. This protein is a glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein that functions as a cell adhesion molecule. It may play a role in the formation of axon connections in the developing nervous system. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]

OMIMResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.48
Clinical SummaryCNTN5
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.33) despite low pLI — interpret in context.
📋
ClinVar Variants
171 VUS of 239 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.48LOEUF
pLI 0.000
Z-score 4.62
OE 0.33 (0.230.48)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
-0.34Z-score
OE missense 1.04 (0.971.11)
599 obs / 576.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.33 (0.230.48)
00.351.4
Missense OE?1.04 (0.971.11)
00.61.4
Synonymous OE?1.16
01.21.6
LoF obs/exp: 18 / 55.0Missense obs/exp: 599 / 576.3Syn Z: -1.77

This gene — mechanism propensity

DN
0.75top 25%
GOF
0.6541th %ile
LOF
0.3550th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

239 submitted variants in ClinVar

Classification Summary

VUS171
Likely Benign18
Benign13
Conflicting2
171
VUS
18
Likely Benign
13
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
0
0
0
0
0
VUS
1
169
1
0
171
Likely Benign
0
7
3
8
18
Benign
0
7
1
5
13
Conflicting
2
Total1183513204

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

17 pathogenic / likely-pathogenic (of 55) ClinVar copy-number / structural variants overlap CNTN5 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CNTN5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →